Related Experiment Video
Updated: Oct 25, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
[Hemolytic uremic syndrome complicated with IgA nephropathy: a clinicopathological study]
1Department of Pathology,Beijing Children's Hospital,Capital Medical University, National Center for Children's Health; Beijing 100045.
Insights
Hemolytic uremic syndrome (HUS) with IgA nephropathy (IgAN) is rare, diagnosed via comprehensive pathology. Plasma exchange and steroids show effectiveness, but long-term prognosis remains uncertain.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Pathology
Background:
- Hemolytic uremic syndrome (HUS) and IgA nephropathy (IgAN) are distinct renal diseases.
- Co-occurrence of HUS and IgAN presents unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To investigate the clinicopathologic features of HUS complicated with IgAN.
- To analyze treatment outcomes and potential mechanisms of this rare condition.
Main Methods:
- Case analysis of two pediatric patients with HUS and IgAN.
- Utilized light microscopy, immunofluorescence, and electron microscopy for renal biopsy analysis.
- Reviewed relevant medical literature.
Main Results:
- Confirmed co-existence of HUS and IgAN with characteristic histopathological findings.
- Patients responded to plasma exchange and steroid therapy.
- Persistent proteinuria and hematuria observed during follow-up, indicating a concerning long-term prognosis.
Conclusions:
- HUS complicated with IgAN is a rare entity requiring integrated diagnostic approaches.
- Plasma exchange and steroids are effective initial treatments.
- Long-term outcomes are variable and potentially linked to disease severity and secondary factors.
Abstract:
Objective: To investigate the clinicopathologic characteristics, treatments, outcomes and mechanisms of hemolytic uremic syndrome (HUS) complicated with IgA nephropathy (IgAN). Methods: The clinical manifestations, treatments, prognosis and histopathological features of renal biopsy tissues were analyzed in two cases of HUS complicated with IgAN from Beijing Children's Hospital, Capital Medical University using light microscopy, immunofluorescence detection and electron microscopy. The related literatures were also reviewed. Results: The clinical manifestations were microvascular hemolytic anemia, thrombocytopenia, acute renal impairment with hematuria, proteinuria, and positive anti-H factor antibody. Histological findings confirmed presence of both HUS and IgAN. Histological features included glomerular mesangial and stromal hyperplasia with endothelial cell proliferation, capillary stenosis, arteriolar thickening, and glomerular ischemia and capillary dilatation. Immunofluorescence detection showed diffuse IgA deposition in the glomerular mesangial matrix. Electron microscopy showed proliferation of mesangial and endothelial cells, thickening of the inner layer of the glomerular basement membrane, deposition of massive electronic densification in the mesangial region, and shrinkage of the segmental basement membrane. The two children were very responsive to plasma exchange and steroid treatments. However, their urine protein and occult blood tests remained continuously positive during the follow-up of 5 years 7 months and 8 months respectively. Conclusions: HUS complicated with IgAN is rare. The diagnosis relies on various pathological examinations, which require the combination of light microscopy, immunofluorescence detection and electron microscopy. Plasma exchange and steroid treatments are effective. However, the long-term prognosis is concerning and may relate to pathological grade and secondary factors. The mechanism of connecting HUS and IgAN is unknown, but may be caused by prodromal or secondary factors.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Pyelonephritis II: Diagnostic Studies and Management